7:31 AM ET
8-K
Investor Presentation
Cerenome Investor Presentation
Cerenome, Inc. (formerly Plus Therapeutics, Inc.) filed an updated corporate presentation as of September 30, 2026, for use in meetings with investors and analysts. The presentation covers the company's clinical trials, strategic collaborations, and the development of its CNSide platform for genomic testing.